Brief: Genmab Says Net Sales Of Darzalex In Q2 $3,539 Mln
July 16 (Reuters) - Genmab A/S GMAB.CO: REG-GENMAB ANNOUNCES NET SALES OF DARZALEX® (DARATUMUMAB) FOR SECOND QUARTER OF 2025 NET SALES OF DARZALEX IN Q2 OF 2025 TOTALED USD 3,539 MILLION Source text: ID:nGNEbc0bTm Further company coverage: GMAB.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos